cabozantinib,atezolizumab
roche
['renal,(-adrenal)', 'contact-03']
presented at #asco23 results of contact-03, co-authored by vhio s , underscore the need to seek new therapeutic strategies to treat patients with metastatic renal cancer that progresses after immunotherapy 
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre